| ➡️ Get instant news updates on Whatsapp. Click here to join our Whatsapp Group. |
Accretion Pharmaceuticals Limited has completed the allotment process for its initial public offering (IPO) on Monday, May 19, 2025. The company raised ₹29.75 crore by issuing 2.94 million new equity shares. The IPO was open for subscription from May 14 to May 16, and it received a strong response from investors, being oversubscribed 7.32 times in total.
Details of the IPO Subscription
The IPO price was set between ₹96 and ₹101 per share, and investors had to apply for a minimum of 1,200 shares. Among different types of investors, the retail investor segment showed great interest, subscribing 8.18 times. Non-Institutional Investors (NII) subscribed 2.65 times, while Qualified Institutional Buyers (QIB) led the demand with an impressive subscription of 10.97 times.
How to Check Your IPO Allotment Status
If you applied for shares in this IPO, you can check your allotment status online through these easy steps:
1. Through KFin Technologies (Registrar’s Website):
- Visit: https://ris.kfintech.com/ipostatus/
- Select ‘Accretion Pharmaceuticals Limited’ from the dropdown menu.
- Enter your PAN, Application Number, or DP Client ID.
- Type the captcha code shown on the screen.
- Click on ‘Submit’ to see your allotment status.
2. Through NSE Website:
- Go to https://www.nseindia.com/invest/check-ipo-allotment-status
- Select ‘Accretion Pharmaceuticals’ as the IPO name.
- Enter your application number or PAN.
- Complete the captcha verification.
- Click ‘Search’ to view your allotment result.
Refund and Share Credit Dates
If your application was not successful, your refund will be processed on May 20, 2025. Those who receive allotment will have shares credited to their demat accounts on the same day.
Grey Market Premium (GMP) Update
Currently, the Grey Market Premium (GMP) for Accretion Pharmaceuticals shares is ₹0. This means the market sentiment is neutral, and shares are expected to list close to the IPO price. Investors are cautiously optimistic about the company’s future.
About Accretion Pharmaceuticals Limited
Founded in 2012, Accretion Pharmaceuticals is a company that manufactures and sells a wide range of pharmaceutical products such as tablets, capsules, oral liquids, and external preparations. They also provide contract manufacturing services to other pharma companies. Their manufacturing plant is based in Sanand, Ahmedabad, Gujarat.
The company follows high-quality and environmental standards, holding certifications like ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005.
Use of IPO Funds
The money raised from this IPO will be used mainly for buying new machinery and upgrading existing manufacturing units. Some funds will also go towards paying off certain loans, managing day-to-day working capital, and other general business purposes.
What This Means for Investors
The strong subscription shows that investors trust Accretion Pharmaceuticals and believe in its growth potential. However, the flat GMP indicates a cautious mood in the market ahead of the stock listing. Investors and analysts will watch closely to see how the company performs once its shares start trading on the stock exchange.
-
-
-
-
-
-
-
-
-
-
-
-
